COV vs PEB

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

COV

CLEO DIAGN FPO [COV]

45LOW

PEB

PACIFIC ED FPO NZX [PEB]

46LOW

Score Breakdown

COV PEB
Technical
44
55
Catalyst
53
51
Sentiment
50
50
Fundamental
60
26
Momentum
64
67
Risk Gate
46
40

Key Metrics

COV Metric PEB
$63.8MMarket Cap$298.0M
122KAvg Volume (20d)31K
N/AShort Interest+0.1%
$0.90052-Week High$0.265
$0.33552-Week Low$0.085
-6.2%Daily Change+0.0%
$0.455Reference Price$0.240
-49.6%ROE-194.7%
-157.4%Profit Margin-275.0%

Active Signals

COV Signals

●RSI drifting toward oversold territory — worth watching
●Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 5.2% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (15 quarters)
●Strong revenue growth (+373%)
●Small-cap ($20-100M)

PEB Signals

●Volume surging at 19.8x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (1.0 quarters)
●Revenue in sharp decline (-46%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●CANSLIM N: Near 52-week high (breakout territory)
●CANSLIM I: Institutional ownership (34%)
●Deeply negative margins (-275%)

Ask Scout AI to compare COV and PEB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

COV vs PKY →COV vs RAC →COV vs RCE →COV vs RHY →COV vs SLD →
COV Full Analysis → PEB Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).